These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25007124)

  • 21. Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidines.
    Gonzàlez Cabrera D; Douelle F; Le Manach C; Han Z; Paquet T; Taylor D; Njoroge M; Lawrence N; Wiesner L; Waterson D; Witty MJ; Wittlin S; Street LJ; Chibale K
    J Med Chem; 2015 Sep; 58(18):7572-9. PubMed ID: 26322748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a new chemical class of antimalarials.
    Brunner R; Aissaoui H; Boss C; Bozdech Z; Brun R; Corminboeuf O; Delahaye S; Fischli C; Heidmann B; Kaiser M; Kamber J; Meyer S; Papastogiannidis P; Siegrist R; Voss T; Welford R; Wittlin S; Binkert C
    J Infect Dis; 2012 Sep; 206(5):735-43. PubMed ID: 22732921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolites of febrifugine and its synthetic analogue by mouse liver S9 and their antimalarial activity against Plasmodium malaria parasite.
    Hirai S; Kikuchi H; Kim HS; Begum K; Wataya Y; Tasaka H; Miyazawa Y; Yamamoto K; Oshima Y
    J Med Chem; 2003 Sep; 46(20):4351-9. PubMed ID: 13678413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substituted Aminoacetamides as Novel Leads for Malaria Treatment.
    Norcross NR; Wilson C; Baragaña B; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Fletcher D; Sinden R; Delves M; Ruecker A; Duffy S; Meister S; Antonova-Koch Y; Crespo B; de Cózar C; Sanz LM; Gamo FJ; Avery VM; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis PA; Read KD; Gilbert IH
    ChemMedChem; 2019 Jul; 14(14):1329-1335. PubMed ID: 31188540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice.
    Gujjar R; El Mazouni F; White KL; White J; Creason S; Shackleford DM; Deng X; Charman WN; Bathurst I; Burrows J; Floyd DM; Matthews D; Buckner FS; Charman SA; Phillips MA; Rathod PK
    J Med Chem; 2011 Jun; 54(11):3935-49. PubMed ID: 21517059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodrugs of reverse fosmidomycin analogues.
    Brücher K; Gräwert T; Konzuch S; Held J; Lienau C; Behrendt C; Illarionov B; Maes L; Bacher A; Wittlin S; Mordmüller B; Fischer M; Kurz T
    J Med Chem; 2015 Feb; 58(4):2025-35. PubMed ID: 25633870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
    Devine SM; Challis MP; Kigotho JK; Siddiqui G; De Paoli A; MacRaild CA; Avery VM; Creek DJ; Norton RS; Scammells PJ
    Eur J Med Chem; 2021 Oct; 221():113518. PubMed ID: 34058708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimalarial activity of 9a-N substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin.
    Perić M; Fajdetić A; Rupčić R; Alihodžić S; Ziher D; Bukvić Krajačić M; Smith KS; Ivezić-Schönfeld Z; Padovan J; Landek G; Jelić D; Hutinec A; Mesić M; Ager A; Ellis WY; Milhous WK; Ohrt C; Spaventi R
    J Med Chem; 2012 Feb; 55(3):1389-401. PubMed ID: 22148880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-cinnamoylation of antimalarial classics: quinacrine analogues with decreased toxicity and dual-stage activity.
    Gomes A; Pérez B; Albuquerque I; Machado M; Prudêncio M; Nogueira F; Teixeira C; Gomes P
    ChemMedChem; 2014 Feb; 9(2):305-10. PubMed ID: 24474655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957.
    Miguel-Blanco C; Murithi JM; Benavente ED; Angrisano F; Sala KA; van Schalkwyk DA; Vanaerschot M; Schwach F; Fuchter MJ; Billker O; Sutherland CJ; Campino SG; Clark TG; Blagborough AM; Fidock DA; Herreros E; Gamo FJ; Baum J; Delves MJ
    Sci Rep; 2021 Jan; 11(1):1888. PubMed ID: 33479319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antimalarial property of orally active phenoxazinium salts.
    Takasu K; Shimogama T; Satoh C; Kaiser M; Brun R; Ihara M
    J Med Chem; 2007 May; 50(10):2281-4. PubMed ID: 17441706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural optimization of quinolon-4(1H)-imines as dual-stage antimalarials: toward increased potency and metabolic stability.
    Ressurreição AS; Gonçalves D; Sitoe AR; Albuquerque IS; Gut J; Góis A; Gonçalves LM; Bronze MR; Hanscheid T; Biagini GA; Rosenthal PJ; Prudêncio M; O'Neill P; Mota MM; Lopes F; Moreira R
    J Med Chem; 2013 Oct; 56(19):7679-90. PubMed ID: 24020770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.
    Van Voorhis WC; Rivas KL; Bendale P; Nallan L; Hornéy C; Barrett LK; Bauer KD; Smart BP; Ankala S; Hucke O; Verlinde CL; Chakrabarti D; Strickland C; Yokoyama K; Buckner FS; Hamilton AD; Williams DK; Lombardo LJ; Floyd D; Gelb MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3659-71. PubMed ID: 17606674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo.
    Tedlaouti F; Gasquet M; Delmas F; Timon-David P; Madadi NE; Vanelle P; Maldonado J
    J Pharm Belg; 1990; 45(5):306-10. PubMed ID: 2086754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids.
    Rodrigues CA; Frade RF; Albuquerque IS; Perry MJ; Gut J; Machado M; Rosenthal PJ; Prudêncio M; Afonso CA; Moreira R
    ChemMedChem; 2015 May; 10(5):883-90. PubMed ID: 25784585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models.
    Schleiferböck S; Scheurer C; Ihara M; Itoh I; Bathurst I; Burrows JN; Fantauzzi P; Lotharius J; Charman SA; Morizzi J; Shackleford DM; White KL; Brun R; Wittlin S
    Drug Des Devel Ther; 2013; 7():1377-84. PubMed ID: 24255594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimalarial Pyrido[1,2- a]benzimidazole Derivatives with Mannich Base Side Chains: Synthesis, Pharmacological Evaluation, and Reactive Metabolite Trapping Studies.
    Okombo J; Brunschwig C; Singh K; Dziwornu GA; Barnard L; Njoroge M; Wittlin S; Chibale K
    ACS Infect Dis; 2019 Mar; 5(3):372-384. PubMed ID: 30608648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazines.
    Priebbenow DL; Mathiew M; Shi DH; Harjani JR; Beveridge JG; Chavchich M; Edstein MD; Duffy S; Avery VM; Jacobs RT; Brand S; Shackleford DM; Wang W; Zhong L; Lee G; Tay E; Barker H; Crighton E; White KL; Charman SA; De Paoli A; Creek DJ; Baell JB
    J Med Chem; 2021 Apr; 64(7):4150-4162. PubMed ID: 33759519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flavones as isosteres of 4(1H)-quinolones: discovery of ligand efficient and dual stage antimalarial lead compounds.
    Rodrigues T; Ressurreição AS; da Cruz FP; Albuquerque IS; Gut J; Carrasco MP; Gonçalves D; Guedes RC; dos Santos DJ; Mota MM; Rosenthal PJ; Moreira R; Prudêncio M; Lopes F
    Eur J Med Chem; 2013 Nov; 69():872-80. PubMed ID: 24125849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triterpenoids as inhibitors of erythrocytic and liver stages of Plasmodium infections.
    Ramalhete C; da Cruz FP; Lopes D; Mulhovo S; Rosário VE; Prudêncio M; Ferreira MJ
    Bioorg Med Chem; 2011 Dec; 19(24):7474-81. PubMed ID: 22071523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.